Partners
In 2013, SAFE-ID receives unrestricted educational grants for the annual programme from the following partners:
Founding partner:
GlaxoSmithKline AG
GlaxoSmithKline AG
Associate partner:
ViiV Healthcare GmbH
ViiV Healthcare GmbH
Supporting partners:
Abbvie AG
Bristol Myers-Squibb SA
Gilead Sciences Switzerland Sàrl
Janssen
Merck Sharp & Dohme-Chibret AG
Abbvie AG
Bristol Myers-Squibb SA
Gilead Sciences Switzerland Sàrl
Janssen
Merck Sharp & Dohme-Chibret AG
In 2013, SAFE-ID receives unrestricted educational grants to support individual events from the following partners:
- No such partnerships finalised yet for 2013
Please contact us should you be interested for partnering for a specific symposium.